Overdose Response Training

Public Group active %s

The Overdose Response Training (ORT) Group is focused on maximizing the resources for reduction and/or prevention of fatal opioid overdose in our community. Administration of naloxone in the setting of an opioid overdose that results in inadequate breathing is considered a harm reduction strategy. Naloxone administration is part of a much larger comprehensive program addressing the opioid epidemic also including education, prevention, and treatment. Classes teaching indications and technique for naloxone administration are held at the Garrett County Health Department (Oakland and Grantsville locations) and at sites outside of the Health Department upon request and availability.

Group Admins
Health Improvement Strategy

Overdose Response Training

https://mygarrettcounty.com/groups/overdose-response-training/

Goal:

Reduce and/or prevent opioid overdose deaths in Garrett County.

Strategy Description:

Reduce and/or prevent opioid overdose deaths in Garrett County through distributing naloxone in the community and educating the community on administration and follow-up steps.  To accomplish this the group will.  Advertise the Overdose Response Training (ORT) classes to the community. Provide classes in a variety of locations and on demand. Distribute naloxone after the completion of training. Work with other organisations to distribute naloxone in high risk settings.  

Level of Change:

Programs

Primary Focus Area:

Behavioral Health: including Substance Abuse and Mental Health

Data Category Tag:

GCHD Behavioral Health

Strategic Planning Alignment:

Estimated Implementation Date:

2017-08-21

Estimated Completion Date:

2022-12-31

Estimated Ease of Implementation:

Easy

Estimated Cost of Implementation:

Low

Potential Community Benefit:

High

Health Equity:

Research:

According to the results of a recent systematic review published in the Annals of Internal Medicine, 2 mg/mL intranasal naloxone may have comparable efficacy and tolerability to intramuscular naloxone. After overdose reversal, the benefits of transport to a hospital remain unclear. Researchers evaluated cohort studies and randomized trials that compared naloxone dosing, administration routes, and transport to a hospital after opioid overdose. Mortality, reversal of overdose, recurrence of overdose, and harms were the main outcomes assessed. Higher-concentration intranasal naloxone (2 mg/mL) was shown to have similar efficacy to intramuscular naloxone (2 mg) in one trial. In another trial, lower-concentration intranasal naloxone (2 mg/5 mL) was associated with lower effectiveness but reduced risk for agitation compared with intramuscular naloxone.     https://bha.health.maryland.gov/NALOXONE/Pages/Naloxone.aspx https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753997/ https://www.clinicalpainadvisor.com/home/topics/opioid-addiction/efficacy-tolerability-of-intranasal-vs-intramuscular-naloxone-for-opioid-overdose/

Skip to content